Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 26, 2026 6:31 AM ・ Updated Jun 14, 2026 12:05 AM ・ 2 min read ・ Source: PR Times
PharmaEssentia announced on May 25, 2026, the completion of a capital reduction by canceling restricted employee shares. The reduction involves 8,000 shares, with minimal impact on financial statements.
PharmaEssentia announced the completion of the registration for capital reduction due to the cancellation of restricted employee shares on May 25, 2026. The regulatory approval and registration completion date was May 25, 2026. The paid-in capital changed from 3,799,093,700 TWD to 3,799,013,700 TWD. The net value per share remains at 92.71 TWD. A total of 8,000 shares were canceled.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.